1Gong C,Hoff JT,Keep RF.Acute inflammatory reaction following experimental intracerebral hemorrhage in rat[J].Brain Res,2000;871(1):57-65.
2Li JJ,Fang CH.C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular disease[J].Med Hypothese,2004;62(4):499-506.
3Gomes MC.C-reactive protein:a new golden marker of cardiovascular risk[J].Rev Port Cardiol,2002;21(11):1329-46.
4Jabs WJ,Logering BA,Gerke P,et al.The kidney as a second site of human C-reactive protein formation in vivo[J].Eur J Immunol,2003;33(1):152-61.
5Angrawal A,Lee S,Carson M,et al.Site-directed mutagenesis of the phosphocholine-binding site of human C-reactive protein:role of Thr76 and Trp67[J].J Immunol,1997;158(1):345-50.
8Rost NS,Wolf PA,Kase CS,et al.Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack:the Framingham study[J].Stroke,2001;32(11):2757-9.
9Gussekloo J,Schaap MC,Frolich M,et al.C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons[J].Arterioscler Thromb Vasc Biol,2000;20(4):1047-51.
6Thompson SG K J, Pyke SDM, Haverkate F, et al. The European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pcctoris. N Engl J Med, 1995, 332: 635-641.
7Haverkate F, Thompson SG, Pyke SD, et al. Production of Creactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet, 1997, 349 : 462 -466.
8Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005, 352: 1685-1695.
9Ridker PM, Cushman M, Stampfer M J, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997, 336: 973-979.
10Mega JL, Morrow DA, Cannon CP, et al. Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy. J Thromb Thrombolysis, 2006, 22: 71-76.
2CAMPBELL D J,NEAL B C,CHALMERS J P,et al.Low-density lipoprotein particles and risk of in-tracerebral haemorrhage in subjects with eerebrovas-cular disease[J].Eurj Cardiovasc Prev Rehabil,2007,14:413-418.
3KRAUS J,OSCHMANN P,LEIS S,et al.High con-centrations of sVCAM-1and sICAM-1in cerebrospi-nal fluid of patients with int racerebral hemorrhage are associated with poor outcome[J].Neurol Neuro-surg Psychiatry,2002,73:346-347.
4JUUL R,HARA H,GISVOLD S E,et al.Alteration in the external jugular veinand in the cerebrospinal fluid following subarachnoid haemorrhage inman[J].Acta Neurchir Wien,1995,132:32-36.
5XUE M,DELBIGIO M R.Intracortical hemorrhage injury in rats relationship between blood fraction and brain cell death[J].Stroke,2000,31:1721-1722.
6FRIJUS C J,KAPPELLE L J.Inflammatory cell ad-hesion molecules is chemic cerebrovascular disease[J].Stroke,2002,33:2115-2122.
7PANTONI L,SARTI C,INZITARI D,et al.Cytokine and cell adhesion molecules in cerebral ischemia:ex-perimental base and therapeutic perspectives[J].Ar-teriscler Thromb Vascbiol,1998,18:503-413.
